Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells

Molecular and Cellular Biochemistry

Volumn 308, Issue 1-2, 2008, Pages 133-139

  Huang, Yue ^a   Fan, Jun ^b   Yang, Jing ^c,d   Zhu, Guo Zhang ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MARSHALL UNIVERSITY   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Glycosylation; GPCR; GPCR proteolytic site; GPR56; Pancreatic cancer; Post translational modification; Suppressed expression

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 56; MESSENGER RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOCHEMICAL COMPOSITION; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; TRANSLATION REGULATION;

ANIMALS; CARBOHYDRATES; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MICE; PANCREATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER;

EID: 38649137249     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9621-4     Document Type: Article

References (25)

1. Bockaert J, Pin JP (1999) Molecular tinkering of G protein-coupled receptors: An evolutionary success. EMBO J 18:1723-1729
2. Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639-650
3. Fredriksson R, Schioth HB (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67:1414-1425
4. Fredriksson R, Gloriam DE, Hoglund PJ, Lagerstrom MC, Schioth HB (2003) There exist at least 30 human G-protein-coupled receptors with long Ser/ Thr-rich N-termini. Biochem Biophys Res Commun 301:725-734
5. Hayflick JS (2000) A family of heptahelical receptor with adhesion-like domains: A marriage between two super families. J Recept Signal Transduct Res 20:119-131
6. Hamann J, Vogel B, Schijndel GM, Lier RA (1996) The seven-span trnasmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 184:1185-1189
7. Shashidhar S, Lorente G, Nagavarapu U, Nelson A, Kuo J, Cummins J, Nikolich K, Urfer K, Foehr ED (2005) GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 24:1673-1682
8. Xu L, Begum S, Hearn DJ, Hynes OR (2006) GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 103:9023-9028
9. Piao X, Hill RS, Bodell A, Chang BS, Vanagaite LB, Straussber R, Dobyns WB, Qasrawi B, Winter RM, Innes AM, et al (2004) G protein-coupled receptor-dependent development of human frontal cortex. Science 303:2033-2036
10. Little KD, Hemler ME, Stipp CS (2004) Dynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: Central role of CD81 in facilitating GPR56-Galpha q/11 association. Mol Biol Cell 15:2375-2387
11. Lorand L, Graham RM (2003) Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140-156
12. Iismaa SE, Begg GE, Graham RM (2006) Cross-linking transglutaminases with G protein-coupled receptor signaling. Sci STKE 353:34
13. Akimov SS, Krylov S, Fleischman LF, Belkin AM (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148:825-838
14. Yeo TP, Hruban RH, Leach SD, et al (2002) Pancreatic cancer. Curr Probl Cancer 26:176-275
15. Wobus M, Vogel B, Schmucking E, Hamann J, Aust G (2004) N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding. Int J Cancer 112:815-822
16. Krasnoperov V, Lu Y, Buryanovsky L, Neubert TA, Ichtchenko K, Petrenko AG (2002) Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS) motif. J Biol Chem 277:46518-46526
17. Davies B, Baumann C, Kirchhoff C, Ivell C, Nubbemeyer R, Habenicht UF, Theuring F, Gottwald U (2004) Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility. Mol Cell Biol 24:8642-8648
18. Liu M, Parker RM, Darby K, Eyre HJ, Copeland NG, Crawford J, Gilbert DJ, Sutherland GR, Jenkins NA, Herzon H (1999) GPR56, a novel secretin-like human G-protein-coupled receptor gene. Genomics 55:296-305
19. Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, Muijen GN (1999) TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential. FEBS Lett 446:292-298
20. Sud N, Sharma R, Ray R (2006) Chattopadhyay TK, Ralhan R, Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett 233:265-270
21. Jin Z, Tietjen I, Bu L, Liu LY, Gaur SK, Walsh CA, Piao X (2007) Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Hum Mol Genet 16:1972-1985
22. Ke N, Sundaram R, Liu G, Chionis J, Fan W, Roger C, Awad T, Grifman M, Yu D, Wong FS, Li QX (2007) Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway. Mol Cancer Ther 6:1840-1850
23. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297:1901-1908
24. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120:1046-1054
25. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu GC, Scarpa A, Croce CM (2006) MicroRNA expression abnormalities in pancreatic end ocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:4677-4684